Skip to main content
VCbacked
Log inGet Started

Nocion Therapeutics

Cambridge, United States

Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.

$62.0M raised
Mar 2024
Series B
BiotechnologyHealth CareMedical

Top Investors

Mission BioCapitalOUP (Osage University Partners)Canaan PartnersF-Prime CapitalArkin Holdings

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nocion Therapeutics

How much funding has Nocion Therapeutics raised?
Nocion Therapeutics has raised $62.0M in total funding. The most recent round was Series B. The last funding was announced in March 2024.
Who are Nocion Therapeutics's investors?
Nocion Therapeutics's investors include Mission BioCapital, OUP (Osage University Partners), Canaan Partners, F-Prime Capital, Arkin Holdings.
Where is Nocion Therapeutics headquartered?
Nocion Therapeutics is headquartered in Cambridge, United States.
What does Nocion Therapeutics do?
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
What stage is Nocion Therapeutics at?
Nocion Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Nocion Therapeutics — Funding & Investors." VCBacked, March 4, 2024, https://www.vcbacked.co/company/nocion-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Nocion Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nocion-therapeutics
Wikipedia (cite web)
{{cite web |title=Nocion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nocion-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong